IP Verse

Syringe

Patent No. EP3679922 (titled "Syringe") was filed by Novartis on May 30, 2013. The application was issued on Oct 8, 2025.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (4)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
TEVA PHARMACEUTICALSApr 28, 2023ELKINGTON AND FIFE
HAMM & WITTKOPPApr 28, 2022HAMM & WITTKOPP
WESSApr 28, 2022SSM SANDMAIR
KEIL & SCHAAFHAUSEN PATENTANWALTE PARTGMBBApr 26, 2022KEIL & SCHAAFHAUSEN PATENTANWALTE PARTGMBB

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3679922

NOVARTIS
Application Number
EP20156274A
Filing Date
May 30, 2013
Status
Patent Maintained As Amended
Sep 5, 2025
Publication Date
Oct 8, 2025
External Links
Slate, EP3679922B2, Google Patents